Marinus Pharmaceuticals Inc (MRNS)
1.41
-0.01
(-0.70%)
USD |
NASDAQ |
Apr 26, 16:00
1.41
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Total Return Level: 1.42 for April 25, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 25, 2024 | 1.42 |
April 24, 2024 | 1.44 |
April 23, 2024 | 1.44 |
April 22, 2024 | 1.475 |
April 19, 2024 | 1.38 |
April 18, 2024 | 1.41 |
April 17, 2024 | 1.44 |
April 16, 2024 | 1.20 |
April 15, 2024 | 1.30 |
April 12, 2024 | 7.52 |
April 11, 2024 | 7.92 |
April 10, 2024 | 8.09 |
April 09, 2024 | 8.38 |
April 08, 2024 | 8.20 |
April 05, 2024 | 7.80 |
April 04, 2024 | 8.68 |
April 03, 2024 | 8.70 |
April 02, 2024 | 8.87 |
April 01, 2024 | 8.97 |
March 28, 2024 | 9.04 |
March 27, 2024 | 8.85 |
March 26, 2024 | 8.79 |
March 25, 2024 | 8.93 |
March 22, 2024 | 8.81 |
March 21, 2024 | 9.01 |
Date | Value |
---|---|
March 20, 2024 | 9.04 |
March 19, 2024 | 9.30 |
March 18, 2024 | 9.02 |
March 15, 2024 | 9.39 |
March 14, 2024 | 8.95 |
March 13, 2024 | 9.44 |
March 12, 2024 | 9.28 |
March 11, 2024 | 8.48 |
March 08, 2024 | 8.85 |
March 07, 2024 | 8.75 |
March 06, 2024 | 9.03 |
March 05, 2024 | 9.24 |
March 04, 2024 | 9.54 |
March 01, 2024 | 9.92 |
February 29, 2024 | 9.50 |
February 28, 2024 | 9.86 |
February 27, 2024 | 10.00 |
February 26, 2024 | 9.99 |
February 23, 2024 | 9.77 |
February 22, 2024 | 9.62 |
February 21, 2024 | 9.75 |
February 20, 2024 | 9.54 |
February 16, 2024 | 9.96 |
February 15, 2024 | 10.00 |
February 14, 2024 | 10.01 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.20
Minimum
Apr 16 2024
20.80
Maximum
Apr 29 2019
9.557
Average
8.81
Median
May 02 2023
Total Return Level Benchmarks
Ligand Pharmaceuticals Inc | 98.65 |
Soligenix Inc | 0.427 |
Actinium Pharmaceuticals Inc | 6.56 |
Macrogenics Inc | 14.37 |
ADMA Biologics Inc | 6.44 |